Status:
COMPLETED
Efficacy of Biofeedback-Based Serious Game for Pain Alleviation in Middle-Aged and Older Ovarian Cancer Patients: A Randomized Controlled Trial
Lead Sponsor:
Shanghai Jiao Tong University School of Medicine
Collaborating Sponsors:
University of Electronic Science and Technology of China
Conditions:
Cancer Pain
Eligibility:
FEMALE
45+ years
Phase:
NA
Brief Summary
Consistent pain affects most middle-aged and older ovarian cancer patients. Non-pharmacological pain interventions, such as serious games, offer a promising approach to alleviating this pain by provid...
Eligibility Criteria
Inclusion
- Meeting the diagnostic standards established by the International Association for the Study of Pain (IASP) and having a pain severity level between 3 and 6 (classified as mild to moderate) at the time of enrollment,
- Diagnosed with ovarian caner
- Demonstrating clear cognitive and expressive abilities,
- Being aged 45 or older,
- Providing voluntary consent after fully understanding the study's objectives.
Exclusion
- Individuals with a history of mental illness or communication disorders,
- Those experiencing vision or cognitive impairments,
- Individuals undergoing pain medication treatment during the intervention period.
Key Trial Info
Start Date :
August 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2024
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT06612489
Start Date
August 1 2023
End Date
January 1 2024
Last Update
September 25 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jianan Zhao
Shanghai, Shanghai Municipality, China, 200021